US FDA May Scrap Clinical Study Report Disclosure For New Drug Approvals

 
• By Derrick Gingery
  
FDA entrance sign 2016
The FDA may shift its focus on improving approval transparency to the integrated review document template instead. • Source: File photo
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Product Reviews

More from Pink Sheet